An experiment at J-PARC, E16 experiment, which aims to measure the spectral modification of vector meson in nuclear matter is planned. The experiment will measure light vector mesons (ρ/ω/ϕ mesons) generated in nuclear target through the 30 GeV p+A reactions. The mass spectra can be reconstructed with e + e − pairs originating from their decays. The spectral modification in finite baryon density is studied systematically. The detail of the experimental plan and expected results are presented with a particular focus on first physics run.
The J-PARC E16 experiment at the upcoming J-PARC high-momentum beam line is proposed to study the spectral modification of vector mesons in nuclei through the 30-GeV p+A reactions. The high precision measurement with high statistics enables to investigate the dependence of spectral modification on the size of target nuclei, and also on the momentum of ϕ mesons systematically. The detectors have been developed and sufficient performances are achieved for the experiment. An expected mass spectrum including achieved performance is presented.
We plan to conduct a new experiment for the γd → pηn reaction using the FOREST detector at the Research Center for Electron Photon Science, Tohoku University, Japan. The main objective is to determine the low-energy η-neutron scattering parameters. The photon beam with energies around 930 MeV can give the recoilless condition of η mesons by detecting the protons at 0• . The effects of the the η-neutron final-state interaction must be enhanced due to the small relative momentum between an η meson and a residual neutron. In this contribution, the planned FOREST experiment is presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.